by National Institutes of Health image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S. Credit: NIAID-RML Early treatment with the experimental antiviral drug remdesivir significantly reduced...
July 10, 2018, Centro Nacional de Investigaciones Cardiovasculares Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have provided valuable information about the defense mechanisms of the immune system during the early stages of the response to pathogens such as viruses and bacteria. The research findings, published today in Nature Communications, contribute to the understanding of the...
Finding could form the basis for potent new drugs ALBERT EINSTEIN COLLEGE OF MEDICINE BRONX, NY–(June 20, 2018)–It’s been known for years that humans and other mammals possess an antiviral gene called RSAD2 that prevents a remarkable range of viruses from multiplying. Now, researchers at Albert Einstein College of Medicine, part of Montefiore, have discovered the secret to the...
